Transforming growth factor-β1 short hairpin RNA inhibits renal allograft fibrosis

Chinese Medical Journal

Volumn 124, Issue 5, 2011, Pages 655-663

  Yin, Zhi Kang ^a   Wu, Xiao Hou ^a   Xia, Yu Guo ^a   Luo, Chun Li ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Fibrosis; Gene therapy; Kidney transplantation; RNA interference; Transforming growth factor beta 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CREATININE; EOSIN; HEMATOXYLIN; NITROGEN; SHORT HAIRPIN RNA; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UREA; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; GENE TARGETING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY FIBROSIS; NONHUMAN; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SHAM PROCEDURE; SIGNAL TRANSDUCTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL TRANSDIFFERENTIATION; EPITHELIAL CELLS; FIBROSIS; KIDNEY; KIDNEY TRANSPLANTATION; MYOFIBROBLASTS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 79952516577     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.05.004     Document Type: Article

References (34)

1. Yoshida K, Endo T, Saito T, Ikeda M, Kamata K, Baba S. Cadaveric renal transplantation from non-heart-beating donors with graft survival for more than 10 years. Transplantation Proceedings 2002; 34: 2604-2607.
2. TA Wynn. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
3. Misseri R, Rink RC, Meldrum DR, Meldrum KK. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res 2004; 119: 149-159.
4. Campistol JM, Iñigo P, Larios S, Bescos M, Oppenheimer F. Role of transplantation. Transforming growth factor-β1 in the progression of chronic allograft nephropathy. Nephrol Dial Transplant 2001; 16: 114-116.
5. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, et al. TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol Gastrointest Liver Physiol 1999; 276: 1059-1068.
6. Bhogal RK, Stoica CM, McGaha TL, Bona CA. Molecular aspects of regulation of collagen gene expression in fibrosis. J Clin Immunol 2005; 25: 592-603.
7. Zeisberg M, Kalluri R. The role of epithelial-to- mesenchymal transition in renal fibrosis. J Mol Med 2004; 82: 175-181.
8. Huijun W, Long C, Zhigang Z, Feng J, Muyi G. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis. Exp Mol Pathol 2005; 78: 17-24.
9. Sui G, Soohoo C, Affarel B, Gay F, Shi Y, Forrester WC, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 2002; 99: 5515-5520.
10. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNA in mammalian cells. Proc Natl Acad Sci U S A 2002; 9: 6047-6052.
11. Xin YP, Lu YP, Zhang XH, Liu XD, Lin T, Gao R, et al. A new rat model of transplant kidney-sclerosis accelerated by prolonged cold ischemla time. J Sichuan Univ (Med Sci Edition) (Chin) 2004; 35: 267-270.
12. Maruyama H, Higuchi N, Kameda S, Nakamura G, Shimotori M, Iino N, et al. Sustained transgene expression in rat kidney with naked plasmid DNA and PCR-amplified DNA fragments. J Biochem 2005; 137: 373-380.
13. Yin ZK, Xia YG, Wu XH, Luo CL, He YF, Liu C. Construction of small hair RNA eukaryotic expression vectors targeting TGF-β1 gene and its inhibitory effects on TGF-β1 gene. J Chongqing Med Univ (Chin) 2009; 34: 27-34.
14. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
15. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al. BMP-7 counteracts TGF-β1 induced epithelial- to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
16. Zavadil J, Böttinger EP. TGF-beta and epithelial-to- mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
17. Xin YP, Yuan GY, Lu YP, Yang YR, Zhang XH, Li YP, et al. Explorative study on mechanism and drug intervention for chronic allograft nephropathy induced by renal ischemia- reperfusion injury. J Sichuan Univ (Med Sci Edition) (Chin) 2007; 38: 918-923.
18. Yin ZK, Wu XH, He YF, Liu C, Du H. Anoxia-reoxygenation up-regulates transcription of TGF-β1 gene in human umbilical veins endotheliaI cell line. J Chongqing Med Univ (Chin) 2008; 33: 694-696.
19. Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, et al. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 2008; 103: 319-327.
20. Qiu J, Tu Z, Shi Y, Zhang L, Li Q, Wang W, et al. Interference of cyclosporine on glucose metabolism: potential role in chronic transplantation kidney fibrosis. Transplant Proc 2006; 38: 2065-2068.
21. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci U S A 2002; 99: 3908-3913.
22. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002; 13: 1464-1472.
23. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.
24. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-1475.
25. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003;112: 1776-1784.
26. Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J Nephrol 2006; 19: 407-412.
27. Dixon A, Maric C. 17 beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Renal Physiol 2007;293: F1678-F1690.
28. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1358-1373.
29. McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45: 268-275.
30. Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, et al. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy. Nephrol Dial Transplant 2006; 21: 2406-2416.
31. Nicholas SB, Aguiniga E, Ren Y, Kim J, Wong J, Govindarajan N, et al. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int 2005; 67: 1297-1307.
32. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 2004; 43: 9-17.
33. Wang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, et al. TGF-β1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006; 81: 48-54.
34. Zhang AQ, Gan WH, Pan XQ. Effects of exogenous connective tissue growth factor on transdifferentiation and extracellular matrix synthesis of human renal tubular epithelial cells. J Fourth Mil Med Univ (Chin) 2007; 28: 1108-1111